News

Cambridge UK – 13 January 2021 – Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, is proud to announce its latest Rare Treatment Accelerator Programme (RTA) partnership with Mission: Cure. This RTA collaboration is the fourth to emerge from the RTA 1.0, which was launched in … Continued

Clinical trials often fail due to poor design and / or endpoint selection. These challenges are often amplified in the rare disease field, where substantial patient heterogeneity exists. In this webinar we will explain the evolution of wearable technologies and digital endpoints, outlining their potential advantages over conventional measurements and monitoring of patients at clinical … Continued